Smiths Medical receives $20M federal funding for syringe production expansion

Smiths Medical partnered with BARDA and the DoD to expand capacity at its Keene, N.H. facility for hypodermic needle and syringe production. BARDA will invest $20 million into a $38 million capital expansion project, and Smiths Medical received an order for 78.6 million syringe and needle units.

“Smiths Medical has received an order through our authorized distributor Marathon Medical’s BARDA IDIQ agreement for 78.6 million syringe and needle units.”medicalbuyer.co.in

• 2 sources
• medicalbuyer.co.inSmiths Medical receives $20M federal funding for COVID-19 vaccine efforts - Medical BuyerPramod SharmaJul 16, 2020
• nhbr.comKeene medical device facility’s parent company wins big vaccine-related contract - NH Business ReviewJeff FeingoldJul 16, 2020

Summarized from public sources; check the original articles before acting on it.